Table 1.
Group | At baseline | At 24 weeks | |
---|---|---|---|
A(control) | Sex | 14(male/female:8/6) | 14(male/female:8/6) |
Age (years old) | 53.40 ± 5.20 | 53.40 ± 5.20 | |
BMI (kg/m2) | 24.06 ± 2.85 | 23.85 ± 2.74 | |
Waistline(cm) | 83.0 ± 6.5 | 81 ± 6.87 | |
B(sitagliptin) | Sex | 17(male/female:10/7) | 17(male/female:10/7) |
Age (years old) | 54.40 ± 9.0 | 54.40 ± 9.40 | |
BMI (kg/m2) | 25.41 ± 3.45 | 24.39 ± 3.02※ | |
Waistline(cm) | 86.9 ± 9.8 | 84.88 ± 8.19※ | |
C(metformin) | Sex | 17(male/female:9/8) | 17(male/female:9/8) |
Age (years old) | 55.63 ± 10.9 | 55.63 ± 10.9 | |
BMI (kg/m2) | 26.46 ± 2.86 | 25.75 ± 3.55※ | |
Waistline(cm) | 88.50 ± 8.00 | 88.67 ± 8.80※ | |
D(Sitagliptin+ metformin) | Sex | 20(male/female:9/11) | 20(male/female:9/11) |
Age (years old) | 54.55 ± 6.6 | 54.55 ± 6.6 | |
BMI (kg/m2) | 26.07 ± 3.24 | 25.53 ± 3.02※ | |
Waistline(cm) | 90.0 ± 8.20 | 86.8 ± 6※ |
Self-pair comparison before and after treatment, ※P<0.05.
Data are number of patients or mean ± standard deviation.
BMI, body mass index.